New Triclazone 80 Tablet

New Triclazone 80 Tablet is a once-daily oral combination medication containing Gliclazide, Pioglitazone, and Metformin for the treatment of Type 2 diabetes. This unique formulation combines three powerful antidiabetic drugs to manage blood glucose levels effectively.

Each tablet contains:

* Gliclazide (80 mg): A sulfonylurea that stimulates insulin secretion from pancreatic beta cells.
* Pioglitazone (15 mg): An oral thiazolidinedione that enhances insulin sensitivity in peripheral tissues, increasing glucose uptake and utilization.
* Metformin (500 mg): A first-line drug for type 2 diabetes mellitus, known for its blood sugar lowering effect by suppressing hepatic gluconeogenesis and inhibiting intestinal glucose absorption.

New Triclazone 80 Tablet is specifically designed to:

* Improve glycemic control in patients with Type 2 Diabetes
* Reduce the risk of long-term complications like cardiovascular disease and neuropathy
* Offer convenience with a single daily dosage

Please consult your healthcare provider before starting any new medication, including this one. This description provides general information; individual needs may vary.

Always read the label and follow the prescribed dosage.